Huang Y - Search Results

1

Membrane transporters and channels in chemoresistance and -sensitivity of tumor cells.

Huang Y, Sadée W. Huang Y, et al. Cancer Lett. 2006 Aug 8;239(2):168-82. doi: 10.1016/j.canlet.2005.07.032. Epub 2005 Oct 5. Cancer Lett. 2006. PMID: 16169662 Review.

2

Membrane transporters and channels: role of the transportome in cancer chemosensitivity and chemoresistance.

Huang Y, Anderle P, Bussey KJ, Barbacioru C, Shankavaram U, Dai Z, Reinhold WC, Papp A, Weinstein JN, Sadée W. Huang Y, et al. Cancer Res. 2004 Jun 15;64(12):4294-301. doi: 10.1158/0008-5472.CAN-03-3884. Cancer Res. 2004. PMID: 15205344

3

Cystine-glutamate transporter SLC7A11 in cancer chemosensitivity and chemoresistance.

Huang Y, Dai Z, Barbacioru C, Sadée W. Huang Y, et al. Cancer Res. 2005 Aug 15;65(16):7446-54. doi: 10.1158/0008-5472.CAN-04-4267. Cancer Res. 2005. PMID: 16103098

4

Chemoresistance to depsipeptide FK228 [(E)-(1S,4S,10S,21R)-7-[(Z)-ethylidene]-4,21-diisopropyl-2-oxa-12,13-dithia-5,8,20,23-tetraazabicyclo[8,7,6]-tricos-16-ene-3,6,9,22-pentanone] is mediated by reversible MDR1 induction in human cancer cell lines.

Xiao JJ, Huang Y, Dai Z, Sadée W, Chen J, Liu S, Marcucci G, Byrd J, Covey JM, Wright J, Grever M, Chan KK. Xiao JJ, et al. Among authors: huang y. J Pharmacol Exp Ther. 2005 Jul;314(1):467-75. doi: 10.1124/jpet.105.083956. Epub 2005 Apr 15. J Pharmacol Exp Ther. 2005. PMID: 15833893

5

ABCB5-mediated doxorubicin transport and chemoresistance in human malignant melanoma.

Frank NY, Margaryan A, Huang Y, Schatton T, Waaga-Gasser AM, Gasser M, Sayegh MH, Sadee W, Frank MH. Frank NY, et al. Among authors: huang y. Cancer Res. 2005 May 15;65(10):4320-33. doi: 10.1158/0008-5472.CAN-04-3327. Cancer Res. 2005. PMID: 15899824

6

Prediction of anticancer drug potency from expression of genes involved in growth factor signaling.

Dai Z, Barbacioru C, Huang Y, Sadée W. Dai Z, et al. Among authors: huang y. Pharm Res. 2006 Feb;23(2):336-49. doi: 10.1007/s11095-005-9260-y. Epub 2006 Jan 26. Pharm Res. 2006. PMID: 16425089

7

Glucose uptake inhibitor sensitizes cancer cells to daunorubicin and overcomes drug resistance in hypoxia.

Cao X, Fang L, Gibbs S, Huang Y, Dai Z, Wen P, Zheng X, Sadee W, Sun D. Cao X, et al. Among authors: huang y. Cancer Chemother Pharmacol. 2007 Mar;59(4):495-505. doi: 10.1007/s00280-006-0291-9. Epub 2006 Aug 12. Cancer Chemother Pharmacol. 2007. PMID: 16906425

8

Chemoinformatics analysis identifies cytotoxic compounds susceptible to chemoresistance mediated by glutathione and cystine/glutamate transport system xc-.

Dai Z, Huang Y, Sadee W, Blower P. Dai Z, et al. Among authors: huang y. J Med Chem. 2007 Apr 19;50(8):1896-906. doi: 10.1021/jm060960h. Epub 2007 Mar 17. J Med Chem. 2007. PMID: 17367118

9

Chemogenomic analysis identifies geldanamycins as substrates and inhibitors of ABCB1.

Huang Y, Blower PE, Liu R, Dai Z, Pham AN, Moon H, Fang J, Sadée W. Huang Y, et al. Pharm Res. 2007 Sep;24(9):1702-12. doi: 10.1007/s11095-007-9300-x. Epub 2007 Apr 25. Pharm Res. 2007. PMID: 17457659

10

Cystine-glutamate transporter SLC7A11 mediates resistance to geldanamycin but not to 17-(allylamino)-17-demethoxygeldanamycin.

Liu R, Blower PE, Pham AN, Fang J, Dai Z, Wise C, Green B, Teitel CH, Ning B, Ling W, Lyn-Cook BD, Kadlubar FF, Sadée W, Huang Y. Liu R, et al. Among authors: huang y. Mol Pharmacol. 2007 Dec;72(6):1637-46. doi: 10.1124/mol.107.039644. Epub 2007 Sep 17. Mol Pharmacol. 2007. PMID: 17875604

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

74,900 results

Search Page